This Is MS Multiple Sclerosis Community: Knowledge & Support

Welcome to the world's leading forum on Multiple Sclerosis research, support, and knowledge. For over 10 years, This is MS has provided an unbiased community dedicated to Multiple Sclerosis patients, caregivers, and affected loved ones.
It is currently Fri May 24, 2013 3:01 pm


All times are UTC - 8 hours [ DST ]




Post new topic Reply to topic  [ 1 post ] 
Author Message
PostPosted: Tue Jun 12, 2012 2:09 am 
Offline
Family Elder
User avatar

Joined: Wed Oct 14, 2009 3:00 pm
Posts: 1689
Image


Genzyme, a Sanofi company , today announced that the company has submitted a supplemental Biologics License Application (sBLA) to the U.S. Food and Drug Administration (FDA) and a marketing authorization application (MAA) to the European Medicines Agency (EMA) seeking approval of Lemtrada(TM) (alemtuzumab) for treatment of relapsing multiple sclerosis (RMS). Genzyme is developing Lemtrada in MS in collaboration with Bayer HealthCare.

Genzyme's clinical development program for Lemtrada included two Phase III studies in which results for Lemtrada were superior to Rebif(R) (high dose subcutaneous interferon beta-1a) on clinical and imaging endpoints, including a reduction in relapse rate. In addition, as presented last month at the American Academy of Neurology meeting, some patients with pre-existing disability treated with Lemtrada in the CARE-MS II trial were more than twice as likely to experience a sustained reduction in disability over two years than patients treated with Rebif.... Read More - http://www.msrc.co.uk/index.cfm/fuseact ... ageid/1307

_________________
The Multiple Sclerosis Resource Centre

Squiffy's House of Fun - Laughter for Multiple Sclerosis


Top
 Profile  
 
Display posts from previous:  Sort by  
Post new topic Reply to topic  [ 1 post ] 

All times are UTC - 8 hours [ DST ]


Related topics
 Topics   Author   Replies   Views   Last post 
There are no new unread posts for this topic. Successful phase III results for Alemtuzumab (Lemtrada(TM*))

squiffy2

14

2620

Sun Aug 19, 2012 6:23 am

Gogo View the latest post

There are no new unread posts for this topic. Lemtrada (alemtuzumab) improved disability scores in MS pts

squiffy2

0

1203

Wed Apr 25, 2012 2:25 am

squiffy2 View the latest post

There are no new unread posts for this topic. Lemtrada (Campath) appears to help MS patients in study

squiffy2

0

838

Mon Oct 24, 2011 12:23 am

squiffy2 View the latest post

There are no new unread posts for this topic. Positive topline results for first phase 3 study of Lemtrada

squiffy2

6

1413

Mon Jul 18, 2011 7:43 am

patientx View the latest post

There are no new unread posts for this topic. Genzyme boasts of durable response to MS drug Lemtrada

squiffy2

2

504

Fri Mar 22, 2013 7:21 am

euphoniaa View the latest post

 


Who is online

Users browsing this forum: No registered users


You cannot post new topics in this forum
You cannot reply to topics in this forum
You cannot edit your posts in this forum
You cannot delete your posts in this forum

Search for:
Jump to: